Medprin Regenerative Medical Technologies Co., Ltd. (SHE:301033)

SHE:301033 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 22, 2026	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	4,943	2,782	2,876	2,436	4,038	-
Market Cap Growth	61.28%	-3.27%	18.06%	-39.66%	-	-
Enterprise Value	4,688	2,604	2,737	2,281	3,756	-
Last Close Price	74.11	41.66	42.69	36.00	59.50	-
PE Ratio	48.08	35.28	70.37	67.88	90.30	-
Forward PE	-	40.83	46.57	-	-	-
PS Ratio	14.68	9.99	12.46	12.48	26.26	-
PB Ratio	6.58	3.98	4.52	4.04	7.01	-
P/TBV Ratio	7.25	4.37	5.08	4.42	7.80	-
P/FCF Ratio	44.40	33.43	42.55	-	-	-
P/OCF Ratio	36.14	23.91	26.71	50.43	60.71	-
EV/Sales Ratio	13.92	9.35	11.85	11.68	24.43	-
EV/EBITDA Ratio	35.36	24.97	40.18	58.51	113.22	-
EV/EBIT Ratio	44.74	32.97	61.91	88.62	139.08	-
EV/FCF Ratio	42.11	31.29	40.48	-	-	-
Debt / Equity Ratio	0	0.00	0.08	0.14	0.19	0.14
Debt / EBITDA Ratio	0.00	0.01	0.76	2.00	3.15	1.55
Debt / FCF Ratio	0.00	0.01	0.79	-	-	-
Asset Turnover	0.42	0.35	0.30	0.26	0.26	0.31
Inventory Turnover	1.66	1.91	1.50	1.24	1.45	1.28
Quick Ratio	6.00	5.80	3.51	2.49	7.25	4.03
Current Ratio	7.08	6.58	3.96	2.91	7.70	4.49
Return on Equity (ROE)	14.41%	11.81%	6.60%	6.07%	9.76%	11.47%
Return on Assets (ROA)	8.24%	6.22%	3.61%	2.16%	2.83%	4.06%
Return on Invested Capital (ROIC)	18.36%	14.52%	7.83%	5.81%	9.95%	13.66%
Return on Capital Employed (ROCE)	13.10%	10.50%	6.10%	3.90%	3.90%	6.50%
Earnings Yield	2.06%	2.83%	1.42%	1.47%	1.11%	-
FCF Yield	2.25%	2.99%	2.35%	-3.60%	-2.14%	-
Dividend Yield	0.81%	1.44%	0.94%	0.56%	0.17%	-
Payout Ratio	39.81%	34.41%	37.38%	22.43%	-	-
Buyback Yield / Dilution	-1.32%	0.33%	0.80%	-17.43%	-14.83%	0.28%
Total Shareholder Return	-0.49%	1.77%	1.74%	-16.88%	-14.66%	0.28%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.